| Objective: to study the mechanism of effect of Abnormal Savda Munziq to the abnormalsavda syndrome typeâ…¡diabets rat. Methods: Metabolic profiling of rat serum and urinesamples from normal control group (n=9), T2DM Abnormal Savda syndrome controlgroup (n=6), T2DM Abnormal Savda syndrome ASM low dose (n=10), medium dose (n=8)and high dose (n=8) treatment groups had been measured by NMR technology combinedwith pattern recognition,Orthogonal Projections to Latent Structures DiscriminantAnalysis (OPLS-DA) and partial least square-discriminant analysis (PLS-DA) method hadbeen used to find out the variability serum and urine metabolits of abnormal savdasyndrome typeâ…¡diabets rat after oral administration of lowã€medium and high dose ofAbnormal Savda Munziq (ASM) for21days. Results:(1) The data analysis showedthat compared with normal control group, the concentration lavel of very low-densitylipoprotein (VLDL)〠low-density lipoprotein (LDL) and carnitine increased while theconcentration level of lactate and β-glucose have decreased in the serum of abnormalsawda syndrome control group,(P<0.05). Except relatively lower concentration level ofscyllitol in the serum of T2DM abnormal sawda syndrome group, Other different groupof samples occurred similar metabolic changes in serum, Which have higher concentrationlevel of β-glucoseã€Î±-Glucose,lower concentration levels of very low-density lipoprotein(VLDL)ã€low-density lipoprotein(LDL)ã€amino acids (including1-methylhistidineã€glycine〠Phenylalanineã€Glutamateã€Tyrosine〠leucineã€isoleucineã€valine) and Citricacidã€Î²-hydroxybutyric acidã€Lactate〠creatineã€lanineã€Î±-oxoglutaric acidã€Carnitineã€succinic acid〠pyruvic acid〠creatinine〠malic acidã€glycoprotein〠acetateã€acetoacetic acidã€compared with normal comtrol group have significant differences,(P<0.05).(2)Compared with normal control group, the concentration lavel of β-glucose〠α-glucoseã€hippuric acidã€2-oxoglutaric acid〠creatineã€Phenylalanine have increased while theconcentration level of lactate and critic acid have decreased in the urine of abnormalsawda syndrome rat,(P<0.05); Other different group of samples occurred similarmetabolic changes in urine, Which have higher concentration levels of β-glucose andα-glucose, lower concentration levels of Citric acid〠β-hydroxybutyric acidã€Lactateã€malic acidã€hippuric acidã€acetoacetic acidã€Î±-oxoglutaric acidã€Carnitineã€creatineã€leucineã€isoleucineã€alanineã€Phenylalanine and glutamate in urine, compared with normal comtrolgroup have significant differences,(P<0.05).(3)After oral administration of ASM, thereduced concentration level of some metabolits including leucine〠isoleucineã€Phenylalanineã€valineã€critic acidã€Î±-oxoglutaric acidã€hippuric acid and formic acid inabnormal savda syndrome typeâ…¡diabets rat serum and urine have been increased,togetherwith, the increased concentration level of β-glucose and α-Glucose in abnormal savdasyndrome typeâ…¡diabets rat serum and urine have been reduced, compared with abnormalsavda syndrome type â…¡ diabets rats group have significant differences,(P<0.05)Conclusion: ASM has significant effects to the abnormal savda syndrome typeâ…¡diabetsrat serum and urine metabolits, specially the high dose of ASM. It`s mechanism of effectmay achieved by readjusting the altered glucose metabolism and amino acid metabolismcaused by abnormal savda syndrome typeâ…¡diabets. |